Here are Wednesday’s biggest calls on Wall Street.
Wednesday’s analyst calls: Goldman says Marriott is a buy, apparel stock to pop 20%
A hotel giant and an apparel name were among the stocks being talked about by analysts on Wednesday.
Wednesday’s big stock stories: What’s likely to move the market in the next trading session
The S&P 500 and the 30-stock Dow touched fresh all-time highs before closing near the flatline on Tuesday. Here’s what CNBC is watching going into Wednesday.
Point72’s Steve Cohen is stepping back from trading his own book
The prominent hedge fund investor, who also owns the New York Mets, will continue his role as the co-chief investment officer at Point72.
Stock market setting itself up for disappointment as it hits all-time high ahead of the Fed
As Wall Street gears up for potential rate cuts from the Fed this week, JPMorgan traders say a quarter-point cut may only exacerbate market uncertainty.
Best dividend stocks to buy as rate cuts make their yields more attractive
Investors can look at these stocks as strong plays amid the upcoming rate-cutting cycle — and also as reliable hedge against any economic slowdown.
The Fed is preparing to cut interest rates. How to revamp your fixed income investments
The central bank’s highly anticipated rate decision is due Wednesday, and money market funds’ yields are about to take a hit.
A growth stock showing signs of a breakout even as investors rotate out of group before Fed
Todd Gordon breaks down the charts in Meta.
How to invest for the next decade with New York Life’s Lauren Goodwin from Future Proof 2024
With interest rates likely to remain volatile, here is where New York Life’s Lauren Goodwin sees opportunities.
Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors
Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical corporate board, writes Ken Squire of 13D Monitor.